Table 2.
Stratified HbA1c analysis in CSII and MDI groups
| Variable | CSII (n=204) |
MDI (n=211) |
p value |
|---|---|---|---|
| Baseline HbA1c (/total n with data) | /193 | /209 | 0.06 |
| <58 mmol/mol (<7.5%), n (%) | 42 (21.8) | 44 (21.1) | |
| 58–75 mmol/mol (7.5–9%), n (%) | 107 (55.4) | 96 (45.9) | |
| >75 mmol/mol (>9%), n (%) | 44 (22.8) | 69 (33) | |
| Change in HbA1c at 1 year (/total n with data) | /189 | /188 | <0.001 |
| >−5 mmol/mol (>−0.5%), n (%) | 98 (51.9) | 55 (29.3) | |
| −5 to 5 mmol/mol (−0.5 to 0.5%), n (%) | 70 (37.0) | 99 (52.7) | |
| >5 mmol/mol (>0.5%), n (%) | 21 (11.1) | 34 (18.1) | |
| Change in HbA1c at study exit (/total n with data) | /142 | /124 | 0.03 |
| >−5 mmol/mol (>−0.5%), n (%) | 63 (44.4) | 36 (29.0) | |
| −5 to 5 mmol/mol (−0.5 to 0.5%), n (%) | 58 (40.8) | 61 (49.2) | |
| >5 mmol/mol (>0.5%), n (%) | 21 (14.8) | 27 (21.8) |
Table showing numbers of all participants stratified to subgroups for baseline HbA1c and change in HbA1c at 1 year and study exit. p values comparing subgroups for all CSII and MDI or matched CSII and MDI cohorts were calculated using χ2 test